IT Consulting and Other Services

Bringspring tech.

Bringspring Tech. released FY2026 Q1 earnings on April 26 After-Market (BJT), actual revenue CNY 107.69 M, actual EPS CNY -0.028

Bringspring Tech. released FY2025 earnings on April 23 After-Market BJT, actual revenue CNY 754.69 M, actual EPS CNY -0.0705

Bringspring Tech. released FY2025 Q4 earnings on April 23 After-Market (BJT), actual revenue CNY 300.99 M, actual EPS CNY -0.021

Bringspring Tech. to Release FY2026 Q1 Earnings on April 27 After-Market BJT

Bringspring tech. FY2025 Annual Earnings Release on April 24, 2026 After-Market (BJT)

Bringspring tech. released FY2025 9 Months earnings on October 27 After-Market (BJT), actual revenue CNY 453.71 M, actual EPS CNY -0.0495

Bringspring Tech. released FY2025 Q3 earnings on October 27 After-Market BJT, actual revenue CNY 162.09 M, actual EPS CNY -0.0069

Bringspring Tech. to Release FY2025 Q3 Earnings on October 28 After-Market (BJT)

Bringspring tech. released FY2025 Q2 earnings on August 21 Pre-Market (BJT), actual revenue CNY 169.98 M, actual EPS CNY -0.0023

Bringspring Tech. released FY2025 Semi-Annual earnings on August 21 Pre-Market BJT, actual revenue CNY 291.62 M, actual EPS CNY -0.0426

Bringspring Tech to Release FY2025 Semi-Annual Earnings on August 22, 2025 (BJT)

Rongke Technology Registers 9 New Software Copyrights

Rongke Technology Q1 2025 Net Profit Declines

Bringspring Tech. released FY2025 Q1 earnings on April 25 After-Market (BJT), actual revenue CNY 121.64 M, actual EPS CNY -0.0402

Bringspring Tech. released FY2024 Q4 earnings on April 21 After-Market (BJT), actual revenue CNY 292.47 M, actual EPS CNY 0.006

Bringspring Tech. released FY2024 Annual Earnings on April 21 After-Market (BJT), Actual Revenue: CNY 767.49 M, Actual EPS: CNY -0.0046

Bringspring Tech. FY2025 Q1 Earnings Release on April 28 After-Market BJT

Investors Question Rongke Technology's Performance and Market Value

Bringspring Tech. FY2024 Annual Earnings Release on April 22, 2025 After-Market BJT

Rongke Technology Board Member Shortage, Extraordinary Shareholders' Meeting Scheduled for April 11, 2025

300290

Bringspring tech. announced that its revenue for the third quarter was 162 million yuan, a year-on-year increase of 0.43%; the net profit loss was 4.4611 million yuan, a decrease of 71.91%. Revenue for the first three quarters was 454 million yuan, a year-on-year decrease of 4.49%; the net profit loss was 31.6901 million yuan, a decrease of 378.82%

Zhitong

Bringspring tech.: Net profit loss of RMB 4.4611 million in the third quarter, a decrease of 71.91%

Regarding the question of whether "Huatai United Securities has filed the major asset restructuring project of Bringspring Tech with the China Securities Association," Bringspring Tech stated on October 16th on the interactive platform that after the company's self-examination and verification with relevant securities firms, there is no such matter. For matters related to the company's capital operations, all information shall be subject to the official announcements released by the company through designated information disclosure media, and do not trust rumors or speculation

Bringspring tech.: "Is it true that Huatai United Securities has filed the major asset restructuring project of Bringspring tech. with the China Securities Association?" The rumor is not true

According to Bringspring tech., recently, Bringspring tech. held a strategic cooperation signing ceremony with Liaoning Fangda General Hospital. The two parties will deeply integrate "technology + healthcare" to build an innovative ecosystem, inject new momentum into the construction of a smart healthcare system, and ultimately achieve the core goals of enhancing patient service experience, optimizing medical resource allocation, and improving hospital operational efficiency

Bringspring Tech. signed a strategic cooperation agreement with Liaoning Fangda General Hospital

Bringspring tech. announced that Vice President Liu Bin holds 253,500 shares of the company, accounting for 0.040%. He plans to reduce his holdings by no more than 63,000 shares, accounting for 0.010%, through centralized bidding within 3 months after 15 trading days from the date of this announcement

Bringspring tech.: Vice President plans to reduce holdings by 0.010% of shares

688692

600536

300352

688152

In the afternoon, the concept of Xinchuang saw a surge, with VRV rising over 15%, and Hunan Kylinsec Technology, Bringspring tech., Dameng Database, Taiji Co., Ltd., and CS&S all rising over 5%

Dameng Database

CS&S

Hunan Kylinsec Technology

The Xinchuang concept experiences a surge, with VRV rising over 15%

Bringspring tech. announced that the operating revenue for 2024 is 767 million yuan, a year-on-year decrease of 3.77%; the net loss attributable to shareholders of the listed company is 2.9195 million yuan, compared to a net profit of 26.5393 million yuan in the same period last year; the basic earnings per share is -0.0046 yuan/share. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital by converting reserves

Bringspring tech.: Net loss of 2.9195 million yuan in 2024

399441

02158

Dongfang Securities released a research report stating that since 2024, AI-related policies have been intensively introduced to fully support the development of AI in healthcare. In 2023, China's AI healthcare market was approximately 8.8 billion yuan, and it is expected to grow to 315.7 billion yuan by 2033, with an average annual growth rate of 43.1%. AI has shown great potential in areas such as drug discovery, medical imaging, and healthcare information technology, capable of improving efficiency, reducing costs, and driving transformation in the biomedicine industry

- Dongfang Securities reports that since the Spring Festival, Deepseek has sparked ongoing interest in the AI industry chain.  
- The ARK report "Big Ideas 2025" highlights that AI and multi-omics will revolutionize drug development, molecular diagnostics, and disease treatment, with China's AI medical market projected to grow from 8.8 billion yuan in 2023 to 315.7 billion yuan by 2033.  
- Key areas of AI application include drug discovery, medical imaging, and healthcare information technology, with significant potential for efficiency improvements and cost reductions, while risks include technological iteration and policy changes.

CNI BIOMEDICINE

YIDU TECH

DFZQ

CHISON MEDICAL

Winning Health

PHARMARON

B-Soft

PHARMABLOCK

LBP Medicine

WUXI APPTEC

HitGen

Medicilon

Lepu Medical

GOODWILL

Meinian Onehealth

Labway

Dongfang Securities: AI empowers biomedicine, with technology and policy support

According to the Zhitong Finance APP, Bringspring tech. disclosed its performance forecast for 2024, estimating a net loss attributable to shareholders of the listed company of RMB 1 million to RMB 13 million; the net loss after deducting non-recurring gains and losses is expected to be RMB 18 million to RMB 30 million

Bringspring tech. issues a profit warning, expecting an annual net loss of 1 million to 13 million yuan

Bringspring tech.(300290.SZ)